Physician
Chi ST. Vincent Medical Group Hot Springs
Chi ST. Vincent Medical Group Hot Springs was paid $13.82M by Medicaid between Jan 2018 and Dec 2024, across 139 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoCHI ST. VINCENT MEDICAL GROUP HOT SPRINGS
HOT SPRINGS, AR 71913
HOT SPRINGS, AR 71913
33aNPI1831387117assigned 10/11/2007
33bProvider typeGeneral Practice Physician
28Total paid$13.82M
24GClaims451,530
24DCodes billed139
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in Arkansas
Rank by total paid#2 of 39
Median peer was paid$49K
This provider vs. median285×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 46,074 | $1.01M | |
| 2019 | 49,313 | $1.35M | |
| 2020 | 77,095 | $2.21M | |
| 2021 | 81,651 | $2.53M | |
| 2022 | 72,740 | $2.33M | |
| 2023 | 72,805 | $2.49M | |
| 2024incomplete | 51,852 | $1.90M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 131,877 | 113,961 | $3.84M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 84,157 | 70,247 | $3.63M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 4.6% | 25,653 | 9,991 | $633K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.2% | 10,549 | 9,699 | $575K |
| 87428 | 3.5% | 7,018 | 6,446 | $477K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 3.4% | 5,088 | 1,900 | $471K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.0% | 7,761 | 7,152 | $410K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 2.7% | 12,377 | 6,247 | $374K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.6% | 6,759 | 6,214 | $363K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.2% | 5,577 | 5,156 | $304K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.6% | 5,144 | 4,706 | $227K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.6% | 3,749 | 3,158 | $216K |
127 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 15,726 | $151K |
| 99203 | Doctor's office visit, new patient (routine) | 1.1% | 3,258 | $146K |
| 80050 | General health panel | 1.0% | 4,566 | $139K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 7,958 | $132K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,352 | $107K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 4,881 | $105K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 711 | $88K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 3,720 | $74K |
| 99223 | Prolong inpt eval add15 m | <1% | 1,209 | $73K |
| 80061 | Lipid panel | <1% | 6,619 | $69K |
| 87400 | <1% | 5,707 | $57K | |
| 90686 | <1% | 5,588 | $52K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,044 | $52K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 483 | $52K |
| 90670 | <1% | 5,240 | $49K | |
| 64493 | <1% | 531 | $45K | |
| 99205 | Prolong outpt/office vis | <1% | 478 | $42K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,119 | $40K |
| 90648 | <1% | 3,764 | $36K | |
| 90680 | <1% | 3,526 | $35K | |
| 87081 | <1% | 4,582 | $35K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,723 | $34K |
| 62322 | <1% | 411 | $33K | |
| 0071A | <1% | 346 | $33K | |
| 99460 | <1% | 368 | $32K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 105 | $31K |
| 87807 | <1% | 2,828 | $30K | |
| 80053 | Comprehensive metabolic panel | <1% | 4,020 | $27K |
| 90723 | <1% | 2,825 | $27K | |
| 0001A | <1% | 1,068 | $27K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 572 | $26K |
| 0002A | <1% | 861 | $25K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 929 | $23K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 430 | $23K |
| 62323 | <1% | 134 | $20K | |
| 76536 | <1% | 585 | $20K | |
| 90697 | <1% | 1,492 | $19K | |
| 87430 | <1% | 1,568 | $18K | |
| 97597 | <1% | 1,406 | $17K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,608 | $17K |
| 90677 | <1% | 1,229 | $16K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,169 | $15K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,064 | $15K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 314 | $15K |
| 90651 | <1% | 1,509 | $14K | |
| 90633 | <1% | 1,448 | $14K | |
| 90734 | <1% | 1,070 | $10K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 594 | $8K |
| 84439 | <1% | 1,477 | $8K | |
| 95911 | <1% | 94 | $7K | |
| 90716 | <1% | 634 | $6K | |
| 90619 | <1% | 417 | $5K | |
| 90707 | <1% | 579 | $5K | |
| 64490 | <1% | 47 | $5K | |
| 90656 | <1% | 329 | $5K | |
| 62320 | <1% | 43 | $5K | |
| 93000 | <1% | 273 | $5K | |
| 84481 | <1% | 475 | $5K | |
| 51798 | <1% | 1,406 | $5K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 279 | $4K |
| 84153 | <1% | 311 | $4K | |
| 90620 | <1% | 408 | $4K | |
| 96127 | <1% | 898 | $3K | |
| 90715 | <1% | 313 | $3K | |
| 92557 | <1% | 76 | $3K | |
| 52000 | <1% | 46 | $3K | |
| 83655 | <1% | 175 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 277 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 652 | $2K |
| 73560 | <1% | 162 | $2K | |
| 94010 | <1% | 266 | $2K | |
| 85027 | <1% | 304 | $2K | |
| 90688 | <1% | 198 | $2K | |
| 94726 | <1% | 289 | $2K | |
| 74018 | <1% | 195 | $2K | |
| 0072A | <1% | 15 | $2K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 34 | $1K |
| 90698 | <1% | 168 | $1K | |
| 81003 | <1% | 1,065 | $1K | |
| 72100 | <1% | 67 | $1K | |
| 81025 | <1% | 250 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 39 | $1K |
| 99243 | <1% | 27 | $1K | |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | <1% | 938 | $1K |
| 93016 | <1% | 519 | $1K | |
| 94729 | <1% | 289 | $1K | |
| 90696 | <1% | 108 | $994.28 | |
| 20610 | <1% | 45 | $924.13 | |
| 90685 | <1% | 103 | $908.20 | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 17 | $855.55 |
| 99381 | <1% | 15 | $854.14 | |
| 95909 | <1% | 13 | $784.89 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 555 | $777.96 |
| 90700 | <1% | 70 | $660.00 | |
| 95816 | <1% | 17 | $622.91 | |
| 74019 | <1% | 39 | $488.74 | |
| 0003A | <1% | 12 | $480.00 | |
| 90674 | <1% | 36 | $473.80 | |
| 80076 | <1% | 196 | $445.20 | |
| 82565 | <1% | 278 | $428.85 | |
| 81001 | <1% | 98 | $423.70 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 641 | $371.37 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 96 | $359.56 |
| 93018 | <1% | 34 | $353.01 | |
| 73030 | <1% | 37 | $329.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 292 | $258.34 |
| 90647 | <1% | 27 | $258.12 | |
| 83615 | <1% | 131 | $246.27 | |
| 85652 | <1% | 299 | $242.27 | |
| 90744 | <1% | 25 | $229.44 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 32 | $198.24 |
| 92567 | <1% | 12 | $198.00 | |
| 51701 | <1% | 16 | $164.22 | |
| 84460 | <1% | 79 | $144.82 | |
| 90380 | <1% | 13 | $144.54 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 129 | $132.73 |
| 84450 | <1% | 79 | $125.46 | |
| 82040 | <1% | 79 | $120.36 | |
| 90710 | <1% | 13 | $120.00 | |
| 87210 | <1% | 19 | $73.20 | |
| 82570 | <1% | 40 | $70.80 | |
| 76604 | <1% | 28 | $29.19 | |
| 82044 | <1% | 40 | $25.96 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 12 | $10.85 |
| 91300 | <1% | 1,181 | $10.53 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 81 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBARNETT, SHAWN (CFO)
| Provider | Location | Paid |
|---|---|---|
| National Kidney Partners, LLP | Hudson, FL | $2.91M |
| Chi ST Vincent Hospital Hot Springs | Hot Springs, AR | $963K |
| ST. Vincent Infirmary Medical Center | Little Rock, AR | $419K |
| Chi ST. Vincent Medical Group Hot Springs | Murfreesboro, AR | $184K |
| Chi ST. Vincent Medical Group Hot Springs | Mount Ida, AR | $182K |
| Chi ST. Vincent Medical Group Hot Springs | Glenwood, AR | $108K |
| Chi ST Vincent Hospital Hot Springs | Hot Springs, AR | $97.40 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.